BIOMAT Database Logo BIOMAT Database Logo

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. 2011

H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. heidi.theeten@ua.ac.be

Susceptibility to vaccine-preventable diseases in Belgium in 2006 was estimated from a serum survey. Immunoglobulins against measles, mumps, rubella (MMR) and diphtheria at all available ages (1-65 years), and against tetanus in >40-year-olds, were measured by ELISA. Age-standardized overall seronegativity for MMR was low (3·9%, 8·0%, 10·4%, respectively). However, the World Health Organization's targets for measles elimination were not met in 5- to 24-year-olds and about 1 in 7 women at childbearing age (15-39 years) were seronegative for rubella. In adults >40 years, tetanus immunity (87·2%, >0·16 IU/ml) largely exceeded diphtheria immunity (20-45%, >0·1 IU/ml). Despite free universal vaccination against MMR for more than 20 years and against diphtheria and tetanus for almost 60 years, our study revealed specific age groups remaining at risk for infection with these pathogens.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009107 Mumps An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) Parotitis, Epidemic,Epidemic Parotitides,Epidemic Parotitis,Parotitides, Epidemic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004165 Diphtheria A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. Corynebacterium diphtheriae Infection,Corynebacterium diphtheriae Infections,Infection, Corynebacterium diphtheriae
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Immunity from diphtheria, tetanus, poliomyelitis, measles, mumps and rubella among adults in Lithuania.
January 1994, Scandinavian journal of infectious diseases,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.
August 2018, Scientific reports,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Vaccination update. Diphtheria, tetanus, pertussis, mumps, rubella, measles.
October 1995, Postgraduate medicine,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps.
September 1975, The Practitioner,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
[Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
April 1998, Schweizerische medizinische Wochenschrift,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
October 2020, The American journal of tropical medicine and hygiene,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
February 1989, Postgraduate medicine,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Childhood lichen planus after simultaneous measles-mumps-rubella and diphtheria-tetanus-pertussis-polio vaccinations.
March 2008, The British journal of dermatology,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Status of immunity to tetanus, measles, mumps, rubella, and polio among U.S. travelers.
July 1991, Annals of internal medicine,
H Theeten, and V Hutse, and N Hens, and Y Yavuz, and K Hoppenbrouwers, and P Beutels, and R Vranckx, and P Van Damme
Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.
January 2003, Vaccine,
Copied contents to your clipboard!